Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-355735

Chief Medical Officer acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tripuraneni Radhika · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-14 Exercise or conversion : show line 1 in the form +40,000 $13.21 $528,400 40,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-14 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −40,000 0 D
Loading xslF345X06/ownership.xml…